The druggable genome and support for target identification and validation in drug development.
about
A PanorOmic view of personal cancer genomes.Drug enrichment and discovery from schizophrenia genome-wide association results: an analysis and visualisation approach.The SGC beyond structural genomics: redefining the role of 3D structures by coupling genomic stratification with fragment-based discovery.Objective, Quantitative, Data-Driven Assessment of Chemical Probes.Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities.Updates in Lupus Genetics.Evidence-Based Precision Oncology with the Cancer Targetome.Genetics of the patent ductus arteriosus (PDA) and pharmacogenetics of PDA treatment.Big data from electronic health records for early and late translational cardiovascular research: challenges and potential.DGIdb 3.0: a redesign and expansion of the drug-gene interaction database.Precision Medicine in Head and Neck Cancer: Myth or Reality?Integrative Bioinformatics Approaches for Identification of Drug Targets in Hypertension.Genetic-Driven Druggable Target Identification and ValidationUncovering new disease indications for G-protein coupled receptors and their endogenous ligands
P2860
Q41510898-310E1E13-A4A3-4269-9793-9405F8EBFB83Q42266399-43C64C63-7953-4D8E-A648-ED6A6369BB6AQ45948895-B71C8C67-BDE9-4FA4-B7D5-8340130B9CD4Q47294977-CC51E003-A1B4-402D-B71B-1D838BE6B076Q47776394-056FBDD8-F948-4AE6-BE7F-DFEAD8EB9A95Q47852851-5F63C76B-689A-4A30-9B0D-891F3A3A4BD4Q47893147-C621DC38-F6D4-468D-B61A-928A3611535FQ50420641-CF72C8D5-D8F7-4286-A3EE-F91199AACC5CQ52705350-807A4961-10D2-4E1B-97DD-CF41F01128A7Q52777528-10B9467C-2AD7-4BF2-897E-4A1E2962346BQ55012383-DDE68278-43D7-4A4A-9258-DBBC8FC2802AQ55346354-948D9DAF-5297-4A80-A771-93ECBEF21E74Q56022528-5F47C0E2-F8A6-49AE-8658-74BB84A5F1BAQ57052680-49A915BB-6E20-4257-9A5F-A211C2AA6FF9
P2860
The druggable genome and support for target identification and validation in drug development.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The druggable genome and suppo ...... alidation in drug development.
@en
The druggable genome and suppo ...... alidation in drug development.
@nl
type
label
The druggable genome and suppo ...... alidation in drug development.
@en
The druggable genome and suppo ...... alidation in drug development.
@nl
prefLabel
The druggable genome and suppo ...... alidation in drug development.
@en
The druggable genome and suppo ...... alidation in drug development.
@nl
P2093
P2860
P50
P1476
The druggable genome and suppo ...... validation in drug development
@en
P2093
Felix A Kruger
Juan P Casas
Luana Galver
R Thomas Lumbers
Ryan Kelley
P2860
P356
10.1126/SCITRANSLMED.AAG1166
P407
P577
2017-03-01T00:00:00Z